论文信息 - The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis. - 字舞流文

The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.

B. Staels | Véronique Touche | S. Lestavel | P. Lefebvre | N. Hennuyer | E. Woitrain | Charlotte Paquet | Isabelle Duplan | Jonathan Vanhoutte | Sophie Colin | Emmanuelle Vallez